Condensed Interim Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Expenses:
Consulting (Note 11)	$ 45,000	$ 24,021	$ 45,000	$ 24,021
Research and development (Note 10)	284,160	147,445	629,623	280,169
Selling, general and administrative (Note 9)	98,571	122,119	194,824	205,525
Stock-based compensation (Note 7)	116,192	190,156	255,840	367,646
Total expenses	543,923	483,741	1,125,287	877,361
Net loss	(543,923)	(483,741)	(1,125,287)	(877,361)
Other comprehensive loss
Currency translation differences	(19,862)	0	(23,884)	0
Total comprehensive loss	$ (563,785)	$ (483,741)	$ (1,149,171)	$ (877,361)
Net loss per share - basic and diluted (in dollars per share)	$ (0.01)	$ (0.00)	$ (0.01)	$ (0.01)
Weighted average number of common shares outstanding – basic and diluted (in shares)	91,422,569	90,357,352	91,422,569	88,482,569